NCT00629837 Pharmacokinetics and Safety of a Single Intravenous Infusion of BAY 79-4980 Status COMPLETED Phase PHASE1
NCT00623727 BAY79-4980 Compared to rFVIII-FS in Previously Treated Patients With Severe Hemophilia A Status TERMINATED Phase PHASE2
NCT00623480 Trial to Evaluate the Effect of Secondary Prophylaxis With rFVIII Therapy in Severe Hemophilia A Adult and/or Adolescent Subjects Compared to That of Episodic Treatment Status COMPLETED Phase PHASE3
NCT00621673 Assessment of the Risk of Inhibitor Formation in Previously Treated Patients With Severe Hemophilia A Status TERMINATED Phase PHASE4
NCT00586521 BAY14-2222 Prophylaxis and Joint Function Improvement (Adults) Status COMPLETED Phase PHASE4
NCT00581438 Study Evaluating Approach to Treatment of Haemophilia A and B in Spain Status COMPLETED Phase N/A
NCT00543439 Study Evaluating Prophylaxis Treatment & Characterizing Efficacy, Safety, & PK Of B-Domain Deleted Recombinant FVIII Status COMPLETED Phase PHASE3
NCT00375323 Recombinant Factor VIIa (NovoSeven) on Restoring Coagulation Activation Status COMPLETED Phase PHASE3
NCT00357656 Phase 3/4 Study of a Recombinant Protein-Free Factor VIII (rAHF-PFM): Comparison of Continuous Infusion Versus Intermittent Bolus Infusion in Hemophilia A Subjects Undergoing Major Orthopedic Surgery Status COMPLETED Phase PHASE4
NCT00306670 Trial of Rituximab Versus Oral Cyclophosphamide to Eradicate or Suppress Autoimmune Anti-Factor VIII Antibodies in Acquired Hemophilia A Status TERMINATED Phase PHASE2/PHASE3
NCT00289536 Dose-Response Study of Recombinant Factor VIII Manufactured Protein-Free (rAHF-PFM) in Patients With Hemophilia A Status COMPLETED Phase PHASE4
NCT00284193 Combination Therapy of Low Doses of rFVIIa and FEIBA for Severe Hemophilia A Patients With an Inhibitor to Factor VIII Status COMPLETED Phase PHASE4
NCT00279578 Clot Formation and Clot Stability in Patients With Severe Haemophilia A Status COMPLETED Phase NA
NCT00245245 Study of Recombinant Porcine Factor VIII (FVIII) in Hemophilia and Inhibitors to FVIII Status COMPLETED Phase PHASE2
NCT00243659 Study Evaluating B-Domain Deleted Recombinant Factor VIII (BDDrFVIII, ReFacto AF) in Patients With Hemophilia A Undergoing Elective Major Surgery Status COMPLETED Phase PHASE3
NCT00243386 Prophylaxis Study of Recombinant Factor VIII Manufactured Protein-Free (rAHF-PFM) in Patients With Hemophilia A Status COMPLETED Phase PHASE4